Introduction and Objectives: A growing body of evidence highlighted the paradigm of interdependence between male and female sexual function as a disorder of the couple. We prospectively evaluated the effect of Stress Urinary Incontinence (SUI) on sexual function of female patients and their respective partners.
Methods: Female patients with SUI who attended the outpatient urology clinics, and their respective partners were asked to participate in the study. A control group which included continent women and their partners were also invited. They were recruited from visitors who were not seeking treatment in the hospital. Eligible couples completed the Golombok Rust Inventory of Sexual Satisfaction (GRISS). A high score suggests a higher degree of sexual problem being measured.
Results: 66 of the 134 couples with female SUI (response rate 49.3%) and 95 of the 176 healthy couples (response rate 54.0%) agreed to participate. There were no differences in the demographic data between females with SUI and healthy controls, or between their respective partners. There was a trend towards increasing overall GRISS scores with advancing age (Spearman’s rank correlation coefficient, r = 0.548, p < 0.001 in female, r = 0.545, p < 0.001 in male).
Females with SUI had significantly higher mean overall scores compared to healthy controls (38.52 ± 10.07 versus 33.74 ± 10.26, p < 0.001). Furthermore, females with SUI reported less frequency in sexual intercourse (p < 0.001), had more sexual dissatisfaction (p < 0.001) and avoidance behavior (p = 0.03). Partners of females with SUI showed significantly higher scores with regards to impotence (p = 0.027), sexual dissatisfaction (p = 0.006) and infrequency of sexual intercourse (p < 0.001). However, there was no significant difference in the overall sexual function as denoted by the total GRISS score (p = 0.093).
Conclusions: Our findings suggest that SUI negatively affects the sexual function of both patients and their partners.
The commonest male ejaculation disorder is Premature Ejaculation (PE). Inhibited or Delayed Ejaculation can be a more challenging condition to assess and treat. This discussion will focus on the diagnosis, investigations and management of ejaculation problems including an overview of the first medication specifically approved for the treatment of PE, dapoxetine, released under the trade name of Priligy™.
Introduction: In 2012, the breast cancer estimate worldwide stood at 1.67 million new cases, these accounting for 25% of all types of cancer diagnosed in women. For 2014, 57,120 new cases are expected, with a risk estimated at 56.1 cases for every 100,000 women. Sexual dysfunction commonly arises in these women following diagnosis and treatment of breast cancer.
Introduction & Objectives: ‘Sexlessness’ was defined as no sexual contact for one month by a Japanese Dr.Teruo Abe in 1990. The tendency of avoidance of sexual intercourse by married couples in Japan has been steadily progressing, as a secondary cause for infertility due to sexlessness. Herein, we investigated as to how the couples’ sexuality changed during pregnancy and in the period after delivery.
The diagnosis of cancer usually is experienced as a major life event. All of a sudden, there is the awareness of mortality and the fear for dying. The subsequent treatment is accompanied by a multitude of physical, sexual, relational, emotional and social changes. Among the various consequences, our profession distinguishes altered sexual function, altered sexual identity and altered sexual relationship.